Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer

BACKGROUND: Breast cancer is the most frequent cancer among women worldwide. Biomarkers for early detection and prognosis of these patients are needed. We hypothesized that deafness, autosomal dominant 5 (DFNA5) may be a valuable biomarker, based upon strong indications for its role as tumor suppres...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Epigenetics
Päätekijät: Croes, Lieselot, Beyens, Matthias, Fransen, Erik, Ibrahim, Joe, Vanden Berghe, Wim, Suls, Arvid, Peeters, Marc, Pauwels, Patrick, Van Camp, Guy, Op de Beeck, Ken
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5896072/
https://ncbi.nlm.nih.gov/pubmed/29682089
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-018-0479-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia